UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 111

Sortiert nach

The Effect of Age on Insulin Sensitivity and Insulin Secretion in First-Degree Relatives of Type 1 Diabetic Patients: A Population Analysis

The journal of clinical endocrinology and metabolism, 2009-07, Vol.94 (7), p.2446-2451

2009

Link zum Volltext

Verfügbarkeit prüfen

On joint railway and housing development strategy

Transportation research. Part B : methodological, 2013-11, Vol.57, p.451-467

2013

Link zum Volltext

Verfügbarkeit prüfen

Modeling transport management and land use over time

Transportation research. Part B: methodological, , Vol.46 (6), p.687-709

Link zum Volltext

Verfügbarkeit prüfen

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity

The New England journal of medicine, 2023-09, Vol.389 (10), p.877-888

2023

Link zum Volltext

Verfügbarkeit prüfen

Effects of Hepatic Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide

Clinical pharmacokinetics, 2022-07, Vol.61 (7), p.1057-1067

2022

Link zum Volltext

Verfügbarkeit prüfen

SOLBINSIRAN, A GALNAC-CONJUGATED SIRNA TARGETING ANGPTL3, REDUCES ATHEROGENIC LIPOPROTEINS IN INDIVIDUALS WITH MIXED DYSLIPIDAEMIA IN A DURABLE AND DOSEDEPENDENT MANNER

Journal of the American College of Cardiology, 2024-04, Vol.83 (13), p.1673-1673

2024

Link zum Volltext

Verfügbarkeit prüfen

769-P: Effect of Food on the Pharmacokinetics, Safety, and Tolerability of Orforglipron (LY3502970), an Oral, Nonpeptide GLP-1 Receptor Agonist

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Link zum Volltext

Verfügbarkeit prüfen

Orforglipron (LY3502970), a novel, oral non‐peptide glucagon‐like peptide‐1 receptor agonist: A Phase 1a, blinded, placebo‐controlled, randomized, single‐ and multiple‐ascending‐dose study in healthy participants

Diabetes, obesity & metabolism, 2023-09, Vol.25 (9), p.2634-2641

2023

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study

The Lancet (British edition), 2023-08, Vol.402 (10400), p.472-483

2023

Link zum Volltext

Verfügbarkeit prüfen

Lepodisiran, an Extended-Duration Short Interfering RNA Targeting Lipoprotein(a): A Randomized Dose-Ascending Clinical Trial

JAMA : the journal of the American Medical Association, 2023-12, Vol.330 (21), p.2075

2023

Link zum Volltext

Verfügbarkeit prüfen

Orforglipron (LY3502970), a novel, oral non‐peptide glucagon‐like peptide‐1 receptor agonist: A Phase 1b, multicentre, blinded, placebo‐controlled, randomized, multiple‐ascending‐dose study in people with type 2 diabetes

Diabetes, obesity & metabolism, 2023-09, Vol.25 (9), p.2642-2649

2023

Link zum Volltext

Verfügbarkeit prüfen

Modeling transport management and land use over time

Transportation research. Part B: methodological, 2012-07, Vol.46 (6), p.687-709

2012

Link zum Volltext

Verfügbarkeit prüfen

761-P: Effect of Orforglipron vs. Placebo and Dulaglutide on Glycemic Control and Body Weight in Patients with Type 2 Diabetes

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Link zum Volltext

Verfügbarkeit prüfen

Generating and Visualizing Spatially Disaggregated Synthetic Population Using a Web-Based Geospatial Service

Sustainability, 2021-02, Vol.13 (3), p.1587

2021

Link zum Volltext

Verfügbarkeit prüfen

Development and Verification of a Body Weight–Directed Disease Trial Model for Glucose Homeostasis

Journal of clinical pharmacology, 2021-02, Vol.61 (2), p.234-243

2021

Link zum Volltext

Verfügbarkeit prüfen

Effect of Food Consumption on the Pharmacokinetics, Safety, and Tolerability of Once-Daily Orally Administered Orforglipron (LY3502970), a Non-peptide GLP-1 Receptor Agonist

Diabetes therapy, 2024-04, Vol.15 (4), p.819-832

2024

Link zum Volltext

Verfügbarkeit prüfen

Simulation-Based Evaluation of Dose Titration Algorithms for U-500R Insulin by Pump in Subjects with Type 2 Diabetes

Journal of diabetes science and technology, 2021-09, Vol.15 (5), p.1195-1197

2021

Link zum Volltext

Verfügbarkeit prüfen

20-OR: GPR142 Agonists Increase Glucose-Dependent Insulin Secretion and Differentially Regulate Hormone Secretion in Preclinical and Phase 1 Studies

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Link zum Volltext

Verfügbarkeit prüfen

Simulation-Based Evaluation of Dose-Titration Algorithms for Rapid-Acting Insulin in Subjects with Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antihyperglycemic Medications

Diabetes technology & therapeutics, 2017-08, Vol.19 (8), p.483

2017

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamics of Glyburide, Metformin, and Glyburide/Metformin Combination Therapy in the Treatment of Gestational Diabetes Mellitus

Clinical pharmacology and therapeutics, 2020-06, Vol.107 (6), p.1362-1372

2020

Link zum Volltext

Verfügbarkeit prüfen

Abstract #269: Pharmacokinetic Bioequivalent and Non-Bioequivalent Concentrated Insulin Formulations: Implications for Clinical use and Dosing

Endocrine practice, 2015-05, Vol.21, p.59

2015

Link zum Volltext

Verfügbarkeit prüfen

Abstract #1215: Human Regular U-500 Insulin Treatment Over 24 Weeks Improves B-Cell Function in Severely Insulin-Resistant Patients with Long-Standing Type 2 Diabetes: A Substudy of A Randomized, Titrationto-Target Clinical Trial

Endocrine practice, 2015-05, Vol.21, p.281

2015

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics and Pharmacodynamics of Human Regular U-500 Insulin Administered via Continuous Subcutaneous Insulin Infusion Versus Subcutaneous Injection in Adults With Type 2 Diabetes and High-Dose Insulin Requirements

Journal of diabetes science and technology, 2022-03, Vol.16 (2), p.401-407

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 111

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(98)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(66)
Life Sciences & Biomedicine
(47)
Humans
(31)
Male
(17)
Adult
(13)
Animals
(13)
Female
(13)
Technology
(13)
Diabetes
(10)
Pharmacokinetics
(10)
Diabetes Mellitus, Type 2 - Drug Therapy
(9)
Endocrinology & Metabolism
(9)
Glucagon
(9)
Middle Aged
(9)
Agonists
(7)
Body Weight
(7)
Diabetes Mellitus
(7)
Engineering
(7)
Leukemia
(7)
Oncology
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

The Effect of Age on Insulin Sensitivity and Insulin Secretion in First-Degree Relatives of Type 1 Diabetic Patients: A Population Analysis

On joint railway and housing development strategy

Modeling transport management and land use over time

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity

Effects of Hepatic Impairment on the Pharmacokinetics of the Dual GIP and GLP-1 Receptor Agonist Tirzepatide

SOLBINSIRAN, A GALNAC-CONJUGATED SIRNA TARGETING ANGPTL3, REDUCES ATHEROGENIC LIPOPROTEINS IN INDIVIDUALS WITH MIXED DYSLIPIDAEMIA IN A DURABLE AND DOSEDEPENDENT MANNER

769-P: Effect of Food on the Pharmacokinetics, Safety, and Tolerability of Orforglipron (LY3502970), an Oral, Nonpeptide GLP-1 Receptor Agonist

Orforglipron (LY3502970), a novel, oral non‐peptide glucagon‐like peptide‐1 receptor agonist: A Phase 1a, blinded, placebo‐controlled, randomized, single‐ and multiple‐ascending‐dose study in healthy participants

Efficacy and safety of oral orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study

Lepodisiran, an Extended-Duration Short Interfering RNA Targeting Lipoprotein(a): A Randomized Dose-Ascending Clinical Trial

Orforglipron (LY3502970), a novel, oral non‐peptide glucagon‐like peptide‐1 receptor agonist: A Phase 1b, multicentre, blinded, placebo‐controlled, randomized, multiple‐ascending‐dose study in people with type 2 diabetes

Modeling transport management and land use over time

761-P: Effect of Orforglipron vs. Placebo and Dulaglutide on Glycemic Control and Body Weight in Patients with Type 2 Diabetes

Generating and Visualizing Spatially Disaggregated Synthetic Population Using a Web-Based Geospatial Service

Development and Verification of a Body Weight–Directed Disease Trial Model for Glucose Homeostasis

Effect of Food Consumption on the Pharmacokinetics, Safety, and Tolerability of Once-Daily Orally Administered Orforglipron (LY3502970), a Non-peptide GLP-1 Receptor Agonist

Simulation-Based Evaluation of Dose Titration Algorithms for U-500R Insulin by Pump in Subjects with Type 2 Diabetes

20-OR: GPR142 Agonists Increase Glucose-Dependent Insulin Secretion and Differentially Regulate Hormone Secretion in Preclinical and Phase 1 Studies

Simulation-Based Evaluation of Dose-Titration Algorithms for Rapid-Acting Insulin in Subjects with Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antihyperglycemic Medications

The Discovery, Preclinical, and Early Clinical Development of Potent and Selective GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus (LY2881835, LY2922083, and LY2922470)

Pharmacodynamics of Glyburide, Metformin, and Glyburide/Metformin Combination Therapy in the Treatment of Gestational Diabetes Mellitus

Discovery of LY3104607: A Potent and Selective G Protein-Coupled Receptor 40 (GPR40) Agonist with Optimized Pharmacokinetic Properties to Support Once Daily Oral Treatment in Patients with Type 2 Diabetes Mellitus

Abstract #269: Pharmacokinetic Bioequivalent and Non-Bioequivalent Concentrated Insulin Formulations: Implications for Clinical use and Dosing

Abstract #1215: Human Regular U-500 Insulin Treatment Over 24 Weeks Improves B-Cell Function in Severely Insulin-Resistant Patients with Long-Standing Type 2 Diabetes: A Substudy of A Randomized, Titrationto-Target Clinical Trial

Pharmacokinetics and Pharmacodynamics of Human Regular U-500 Insulin Administered via Continuous Subcutaneous Insulin Infusion Versus Subcutaneous Injection in Adults With Type 2 Diabetes and High-Dose Insulin Requirements

Suchergebnisse filtern